Hook + thesis
Celestica is no longer just a contract manufacturer riding hardware cycles. The company landed a high-visibility partnership with AMD to produce networking switches for the Helios rack-scale AI platform, and the market is only beginning to price in the strategic value of that deal. Pair that catalyst with solid profitability metrics - a return on equity north of 37% and positive free cash flow - and you have the kind of asymmetric opportunity I want to own for the next several quarters.
My thesis is straightforward: buy Celestica at current levels as a long-term trade. The combination of a credible AI/data-center growth vector, improving technical momentum, and a balance sheet that supports reinvestment and capital returns reduces downside compared with prior cycles. I am upgrading Celestica to a Buy and recommend building a position in tranches, using the trade plan below.
What the company does and why the market should care
Celestica provides outsourced electronics manufacturing and supply chain solutions through two main segments: Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS). ATS covers aerospace and defense, industrial, health tech and smart energy. CCS handles enterprise communications, telecommunications, servers and storage - essentially the businesses that scale data center and networking hardware. That latter piece is central to the bull case: supply-chain complexity and scale manufacturing are barriers that favor experienced contract manufacturers as cloud and enterprise customers rush to deploy AI infrastructure.
Why this matters now: Celestica announced a partnership with AMD to develop and manufacture networking switches for AMD's Helios rack-scale AI platform (03/16/2026). Helios is aimed at large AI cluster deployments where turn-key rack-level integration and optimized networking matter. This is the sort of multi-year, high-volume program that can move the revenue needle for a solutions-oriented EMS provider and create sticky, higher-margin work compared with one-off board builds.
Support for the argument - numbers that matter
| Metric | Value |
|---|---|
| Current price | $293.99 |
| Market cap | $33,799,626,268.80 |
| Enterprise value | $34,078,022,073.00 |
| EPS (TTM) | $7.24 |
| P/E | ~41x |
| P/S | ~2.74x |
| Free cash flow (annual) | $458.3M |
| Return on equity | 37.56% |
| Debt / Equity | 0.35 |
Those numbers sketch a clear picture. Celestica is a sizeable company with a market cap approaching $34B and an enterprise value just over $34B. Profitability metrics are strong for an EMS firm: ROE of 37.56% and ROA of 11.54% indicate efficient use of capital. The company is producing free cash flow ($458.3M annually), but the price-to-free-cash-flow multiple (~74x) and P/E (~41x) suggest the equity is priced for continued margin expansion and above-average growth.
On the technical side, momentum is constructive. The 10/20/50-day moving averages sit below current price, MACD shows bullish momentum, and the RSI is benign at 54.3 - not overbought. Short interest is moderate with two days to cover as of the latest settlement, which limits the risk of a sudden short squeeze but also indicates limited bearish pressure.
Valuation framing
At roughly $34B market cap and $458M in free cash flow, Celestica trades at a low single-digit free cash flow yield (~1.4%). That is expensive relative to mature industrials but not wildly out of line for companies positioned to capture AI and data-center growth. The stock has traded as low as $58 in the 52-week window and hit a high of $363 - the range shows the stock can re-rate quickly based on narrative and contract wins. The current valuation appears to price in meaningful margin leverage and multi-year revenue from high-value programs like Helios.
In short: valuation is not cheap on headline multiples. You are paying for growth and strategic exposure to AI infrastructure. The question is whether Celestica can convert program wins into scale and sustained higher margins. Recent profitability metrics and a reasonable balance sheet - debt-to-equity of 0.35 - make that outcome credible, though not guaranteed.
Catalysts to watch (2-5)
- AMD Helios program ramp - incremental design wins and production milestones tied to AMD could materially boost revenue in CCS over the next 6-18 months. (Announcement: 03/16/2026).
- Quarterly results showing margin expansion - any evidence that higher-margin systems or services revenue is growing faster than low-margin assembly would support the current multiple.
- New customer wins in enterprise cloud or hyperscale - additional multi-year contracts would de-risk revenue concentration and justify multiple expansion.
- Shares repurchases or disciplined capital allocation announced alongside improved FCF conversion - could tighten float and support the stock.
Trade plan (actionable)
My actionable trade is a long position with a time horizon of long term (180 trading days). I expect the position to be built in tranches and held through the potential Helios ramp and upcoming quarterly prints that will reveal margin traction.
| Action | Price |
|---|---|
| Entry | $295.00 |
| Primary target | $365.00 |
| Stop loss | $255.00 |
How I would implement: initiate a 50% tranche at $295, add the second tranche on pullback toward $275 or on confirmation of revenue/margin beat. The stop loss at $255 limits downside if the stock loses the Helios narrative or broader hardware demand collapses. The $365 target reflects a re-rating toward the recent 52-week high ($363.40 on 11/05/2025) and assumes continued program execution and margin improvement. If the company reports sustained margin expansion or additional high-value wins, I would raise the target and potentially add to the position.
Risks and counterarguments
- Customer concentration and program risk. A substantial portion of high-value revenue can come from a handful of customers. Reports in February indicated potential exposure to shifts in one large customer's server assembly plans (investigation news on 02/17/2026). If a major customer reallocates work or reduces volumes, revenue and margin assumptions crumble quickly.
- Valuation vulnerability. The stock trades at P/E ~41 and P/FCF ~74x. If growth disappoints or margin expansion stalls, multiple compression could erase gains even if absolute fundamentals remain stable.
- Competition and supply-chain squeeze. Larger contract manufacturers or in-house hyperscalers could win designs. Additionally, component shortages or rising input costs would compress margins.
- Legal/operational risk. There is an active investigation (02/17/2026) tied to customer allocation of assembly work. Litigation or negative findings could be a headline catalyst for weakness.
- Macro demand shift. AI infrastructure spending is lumpy and sensitive to enterprise and cloud capital cycles; a macro slowdown could delay or cancel planned deployments.
Counterargument: skeptics will point to the high multiple and the Pomerantz investigation referencing potential customer shifts as reasons to avoid Celestica. Those are valid concerns. However, Celestica's ROE and positive free cash flow indicate the company can withstand cyclical downdrafts, and the AMD Helios partnership demonstrates product-level differentiation versus commodity board assembly. If Helios becomes a multi-rack program across cloud providers, the upside could be material and justify current multiples.
What would change my mind
I will downgrade or exit the trade if: (1) the company confirms a material loss of a major customer or a substantive revenue reversal tied to server assembly contracts; (2) the quarterly cadence shows shrinking gross margins without offsetting expense discipline; or (3) management materially increases leverage or makes capital allocation choices that erode shareholder value. Conversely, I will add to the position if Celestica posts consecutive quarters of margin expansion, confirms multi-year volume commitments for Helios, or announces additional high-value OEM programs.
Conclusion
Celestica is no cheap turnaround play anymore - you are paying a premium for growth and strategic AI/data-center exposure. I still like the risk/reward because the AMD Helios partnership can convert into predictable, higher-margin systems work and because the company prints real free cash flow and strong returns on equity. For patient investors willing to tolerate valuation risk over the next 180 trading days, this is a Buy with a clear trading plan: entry $295.00, stop $255.00, target $365.00. Build in tranches, watch the Helios ramp and quarterly margin trajectory, and be ready to trim if the macro or customer picture deteriorates.